Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Loading ONVO News...
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||-0.80%||69.29||1.0%||$931.38m|
|REGN||Regeneron Pharmaceuticals, Inc.||0.12%||371.61||1.9%||$348.38m|
|ALXN||Alexion Pharmaceuticals, Inc.||0.83%||129.89||2.0%||$299.57m|
|VRTX||Vertex Pharmaceuticals Incorporated||-2.02%||86.55||2.6%||$140.07m|
|CLVS||Clovis Oncology, Inc.||-4.27%||62.99||16.4%||$132.37m|
|A||Agilent Technologies, Inc.||-0.54%||51.35||1.7%||$117.26m|
|ACAD||ACADIA Pharmaceuticals Inc.||-0.20%||39.20||19.0%||$93.83m|
|BMRN||BioMarin Pharmaceutical Inc.||0.41%||90.24||4.0%||$89.98m|
Organovo Holdings, Inc. is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo Holdings was founded on January 30, 2012 and is headquartered in San Diego, CA.